Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDE4B antisense RNA 1 (PDE4B-AS1) is a long non-coding RNA transcribed from the genomic locus antisense to the PDE4B gene. Like other naturally occurring antisense RNAs, it may participate in the regulation of its sense counterpart (PDE4B) by altering mRNA levels, processing, or translation, but no detailed functional studies are available linking PDE4B-AS1 itself to specific biological processes or human disease. At present, it is not recognized as a therapeutic target, and very little specific literature exists about its functions or clinical significance. Key distinction: PDE4B-AS1 is a non-coding RNA transcript, not the protein-coding enzyme phosphodiesterase 4B (PDE4B), which is a characterized drug target. Most literature and drug development relates to PDE4B, not PDE4B-AS1.
None known. No mechanism for drug action on PDE4B-AS1 is described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDE4B antisense RNA 1 (PDE4B-AS1).